Rchr
J-GLOBAL ID:202301015799045775   Update date: Dec. 05, 2023

Ishikura Teruyuki

イシクラ テルユキ | Ishikura Teruyuki
Affiliation and department:
Research theme for competitive and other funds  (1):
  • 2020 - 2023 治療層別化に向けた原因不明自己免疫性脳炎single-cell病態解析
Papers (17):
  • Mikito Shimizu, Naoyuki Shiraishi, Satoru Tada, Tsutomu Sasaki, Goichi Beck, Seiichi Nagano, Makoto Kinoshita, Hisae Sumi, Tomoyuki Sugimoto, Yoko Ishida, et al. RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS. Science advances. 2023. 9. 47. eadg3193
  • Teruyuki Ishikura, Tomohito Nakano, Takaya Kitano, Takechiyo Tokuda, Hisae Sumi-Akamaru, Takashi Naka. Serum ferritin level during hospitalization is associated with Brain Fog after COVID-19. Scientific reports. 2023. 13. 1. 13095-13095
  • Teruyuki Ishikura, Tatsusada Okuno, Toshiyuki Takahashi, Hideki Mochizuki. Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease with Frequent Cerebellitis. Internal medicine (Tokyo, Japan). 2022. 61. 23. 3629-3630
  • Naohiro Fujita, Teruyuki Ishikura, Nozomi Nagashima, Akira Nishikawa, Hisae Sumi-Akamaru, Takashi Naka. [Rippling muscle disease with myasthenia gravis]. Rinsho shinkeigaku = Clinical neurology. 2022. 62. 7. 563-566
  • Tomoya Wadayama, Mikito Shimizu, Tomohiro Yata, Teruyuki Ishikura, Yuta Kajiyama, Daisuke Hirozawa, Tatsusada Okuno, Hideki Mochizuki. Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment. Journal of neuroimmunology. 2022. 363. 577789-577789
more...
MISC (8):
  • Okuno Tatsusada, Kinoshita Makoto, Ishikura Teruyuki. Investigation of pathology and development of therapeutics of NMO using NMO animal models. Neurological Therapeutics. 2021. 38. 4. 526-530
  • Watanabe Kotaro, Okazaki Shuhei, Taniguchi Mariko, Kakigano Aiko, Kitano Takaya, Hideshima Makoto, Ishikura Teruyuki, Nakano Tomohito, Jinno Jyunki, Todo Kenichi, et al. Stroke in postpartum reversible cerebral vasoconstriction syndrome. Japanese Journal of Stroke. 2020. 42. 4. 253-257
  • 島村 宗尚, 新崎 信一郎, 池中 建介, 小仲 邦, 廣澤 太輔, 石倉 照之, 秀嶋 信, 中野 智仁, 北野 貴也, 竹原 徹郎, et al. レボドパ/カルビドパ配合経腸用液療法14例におけるPEG-J関連合併症の検討. 臨床神経学. 2019. 59. 3. 153-156
  • 中野 智仁, 廣澤 太輔, 石倉 照之, 秀嶋 信, 神野 隼輝, 津田 浩史, 佐々木 勉, 長野 清一, 望月 秀樹. Facial onset sensory and motor neuronopathy(FOSMN)の一例. 臨床神経学. 2018. 58. 12. 790-790
  • 南波 明子[細川], 中辻 裕司, 甲田 亨, 山下 和哉, 清水 幹人, 石倉 照之, 木下 允, 望月 秀樹, 熊ノ郷 淳, 奥野 龍禎. 基礎研究・動物モデル 血清Sema4A高値多発性硬化症患者がIFNβ抵抗性を呈する機序についての検討. 神経免疫学. 2018. 23. 1. 111-111
more...
Education (2):
  • - 2021 Osaka University Graduate School of Medicine
  • - 2013 Osaka University Faculty of Medicine
Awards (3):
  • 2021/12 - 日本多発性硬化症協会 医学研究助成
  • 2021/10 - 日本神経治療学会 優秀演題賞
  • 2012/04 - 日本内科学会 ポスター演題優秀賞
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page